Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2341
Influence of Patient Baseline Characteristics on Zasocitinib (TAK-279) Efficacy, a Selective Oral Tyrosine Kinase 2 Inhibitor: A Randomized Phase 2b Trial in Psoriatic Arthritis
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 1801
Inhibitory Effects of Dapirolizumab Pegol, a Monovalent Anti-CD40L PEG-Conjugated Antigen-Binding Fragment Lacking a Functional Fc Domain, on In Vitro T Follicular Helper/B Cell Interactions and Cytokine Production in Systemic Lupus Erythematosus
SLE – Etiology & Pathogenesis Poster- 10:30AM-12:30PM
-
Abstract Number: 1991
Initial Corticosteroid Dosing and Effects on Disease Activity, Survival, and Tumor Progression in Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 1978
Insertional and Midportion Achilles Tendinopathy Have Differences in Presence of Calcifications and Neovascularization
Imaging of Rheumatic Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 1922
Insights into Rheumatology Practice in Uganda
Healthcare Disparities in Rheumatology Poster III- 10:30AM-12:30PM
-
Abstract Number: 1819
Insulin-like Growth Factor Binding Protein-7 (IGFBP7) Plays a Pathogenic Role in Dermal Fibrosis and Is Increased in Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Basic Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2358
Integration of Single-cell Multi-omics Profiling for Investigating Treatment Response to Tumor Necrosis Factor Alpha Inhibitors in Patients with Axial Spondyloarthritis
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 1952
Interest in Clinical Trial Participation Among People with Lupus: Results from the Research Accelerated by You (RAY) Registry
Health Services Research – ACR/ARP Poster III- 10:30AM-12:30PM
-
Abstract Number: 2288
Interferon Gamma Signaling Is Associated with Development of Extraglandular Manifestations in Sjögren’s Disease
Sjögren's Syndrome – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2463
Interstitial Lung Disease in Very Early Systemic Sclerosis – a Clinical and Radiological Characterization
Systemic Sclerosis & Related Disorders – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 2271
Intra-Articular Injection of Human Bone Marrow-Derived Mesenchymal Stem Cells in Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Trial
RA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 1804
Investigating Adaptive Immune Receptor Repertoires by Deep Immune Cell Phenotyping in Preclinical Autoimmunity Development
SLE – Etiology & Pathogenesis Poster- 10:30AM-12:30PM
-
Abstract Number: 2441
Investigating Kidney Disease Risks in Systemic Sclerosis (SSc) – Effects of Proton Pump Inhibitors (PPI): Retrospective Analysis
Systemic Sclerosis & Related Disorders – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 2319
Investigating the Association of Serum Metabolites with Psoriatic Arthritis Musculoskeletal Disease Patterns